Indication
LTBI
1 clinical trial
4 products
Clinical trial
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected IndividualsStatus: , Estimated PCD: 2025-02-28
Product
DolutegravirProduct
IsoniazidProduct
RifapentineProduct
Antiretroviral Therapy